SENIOR LEADERSHIPSince the previous review, there has been significant recruitment and promotion of key individuals to seniorleadership positions to expand the Cancer Center leadership from five positions (Director and four AssociateDirectors) to eight.The Center Director, Theodore Krontiris, MD, PhD, in his capacity as Center Director and as Executive VicePresident for Medical and Scientific Affairs of City of Hope, is the chief means by which all organizationalentities and inherent capabilities are integrated in the research of the Cancer Center. As EVPMSA, heoversees the derivation and renewal of the Institutional strategic plan. Through his collaboration with, andoversight of, the COH Beckman Research Institute (BRI) Director and the COH National Medical Center (NMC)Chief Medical Officer, he assures that faculty hiring in the BRI and NMC, respectively, conforms to the strategicplan and is consonant with needs of the Cancer Center Programs for expanding their interdisciplinaryresearch activities, as well as addressing peer-review and external advisors' recommendations about the stateof the Center.The Deputy Director, Richard Jove, PhD, recruited from H. Lee Moffitt Cancer Center, has substantialexperience in leading translational research programs. He oversees the implementation of the overall Centerstrategy and has scientific oversight of Shared Resources. The AD for Administration, Michael Benedict,PharmD, oversees all office operations and CCSG management, and has administrative oversight of SharedResources. Robert Figlin, MD, AD for Clinical Research, was recently recruited from UCLA. He oversees allclinical cancer activities and the coordination of all cancer clinical trials. Yun Yen, MD, PhD, is the AD forTranslational Research, a new leadership position since the previous review. He is responsible for integratingcorrelative laboratory studies into clinical trials. In addition, Drs. Yen and Figlin co-chair the Task Force forCancer Center Disease Program Development (see Essential Characteristics), which includes the DeputyDirector and the other ADs as members. Smita Bhatia, MD, a national leader in cancer survivorship studies,was promoted to AD for Population Research and is responsible for developing research directions in cancerprevention and control. John Rossi, PhD, is a longtime leader in RNA biology and continues to fostersuccessful interdisciplinary collaborations within the Cancer Center membership as part of his role as AD forBasic Research. Joyce Niland, PhD, with her outstanding experience in medical informatics, was appointedAD for Information Sciences, a new AD position concomitant with the increasing role of informatics in CancerCenter operations.In addition to the qualifications and roles of each of the Senior Leadership positions described on the followingpages, many of these Cancer Center leaders are Division Chairs or Department Directors within BRI or NMC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-25
Application #
7714106
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2012-11-30
Budget Start
2008-09-01
Budget End
2008-11-30
Support Year
25
Fiscal Year
2008
Total Cost
$28,365
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Tirughana, Revathiswari; Metz, Marianne Z; Li, Zhongqi et al. (2018) GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System. Mol Ther Methods Clin Dev 10:48-56
Raz, Dan J; Wu, Geena X; Consunji, Martin et al. (2018) The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography. Clin Lung Cancer 19:51-57
Solomon, Ilana; Rybak, Christina; Van Tongeren, Lily et al. (2018) Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. J Cancer Educ :
Wang, Dongrui; Aguilar, Brenda; Starr, Renate et al. (2018) Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. JCI Insight 3:
Cheng, Chun-Ting; Qi, Yue; Wang, Yi-Chang et al. (2018) Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction. Commun Biol 1:178
Cho, H; Ayers, K; DePills, L et al. (2018) Modelling acute myeloid leukaemia in a continuum of differentiation states. Lett Biomath 5:S69-S98
Querfeld, Christiane; Leung, Samantha; Myskowski, Patricia L et al. (2018) Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer Immunol Res 6:900-909
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Das, Sadhan; Reddy, Marpadga A; Senapati, Parijat et al. (2018) Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms. Arterioscler Thromb Vasc Biol 38:1806-1820
Al Malki, Monzr M; Nathwani, Nitya; Yang, Dongyun et al. (2018) Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:1828-1835

Showing the most recent 10 out of 1396 publications